Tetsuo Nakano

1.3k total citations
37 papers, 1.0k citations indexed

About

Tetsuo Nakano is a scholar working on Orthopedics and Sports Medicine, Surgery and Oncology. According to data from OpenAlex, Tetsuo Nakano has authored 37 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Orthopedics and Sports Medicine, 17 papers in Surgery and 11 papers in Oncology. Recurrent topics in Tetsuo Nakano's work include Bone health and osteoporosis research (21 papers), Bone health and treatments (11 papers) and Hip and Femur Fractures (11 papers). Tetsuo Nakano is often cited by papers focused on Bone health and osteoporosis research (21 papers), Bone health and treatments (11 papers) and Hip and Femur Fractures (11 papers). Tetsuo Nakano collaborates with scholars based in Japan, United States and Australia. Tetsuo Nakano's co-authors include Hiroshi Hagino, Toshitaka Nakamura, Masako Ito, Naoto Endo, Masao Fukunaga, Masataka Shiraki, Takeshi Sawaguchi, Yoshinobu Watanabe, Toshitsugu Sugimoto and Teruki Sone and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, The Journal of Nervous and Mental Disease and Calcified Tissue International.

In The Last Decade

Tetsuo Nakano

31 papers receiving 1000 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tetsuo Nakano Japan 17 660 478 381 243 121 37 1.0k
Albrecht W. Popp Switzerland 18 550 0.8× 289 0.6× 306 0.8× 199 0.8× 103 0.9× 33 891
D. Algra Netherlands 11 644 1.0× 311 0.7× 259 0.7× 263 1.1× 128 1.1× 11 1.3k
Romain Perrelet Switzerland 12 551 0.8× 338 0.7× 208 0.5× 165 0.7× 185 1.5× 20 865
Tsutomu Hashimoto Japan 20 255 0.4× 389 0.8× 117 0.3× 110 0.5× 148 1.2× 53 921
Anna G Nilsson Sweden 18 347 0.5× 267 0.6× 171 0.4× 252 1.0× 50 0.4× 30 1.3k
Christopher Shuhart United States 10 547 0.8× 284 0.6× 116 0.3× 96 0.4× 138 1.1× 14 925
Richard P. Tonino United States 11 1.8k 2.7× 338 0.7× 1.6k 4.1× 667 2.7× 117 1.0× 17 2.3k
Giuseppina Resmini Italy 14 280 0.4× 168 0.4× 101 0.3× 144 0.6× 81 0.7× 30 573
T. Hashimoto Japan 16 302 0.5× 351 0.7× 72 0.2× 60 0.2× 103 0.9× 27 720
S. Pouwels Netherlands 12 217 0.3× 204 0.4× 59 0.2× 73 0.3× 61 0.5× 24 655

Countries citing papers authored by Tetsuo Nakano

Since Specialization
Citations

This map shows the geographic impact of Tetsuo Nakano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsuo Nakano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsuo Nakano more than expected).

Fields of papers citing papers by Tetsuo Nakano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tetsuo Nakano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsuo Nakano. The network helps show where Tetsuo Nakano may publish in the future.

Co-authorship network of co-authors of Tetsuo Nakano

This figure shows the co-authorship network connecting the top 25 collaborators of Tetsuo Nakano. A scholar is included among the top collaborators of Tetsuo Nakano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tetsuo Nakano. Tetsuo Nakano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Soen, Satoshi, Kazuhiko Yamamoto, Tsutomu Takeuchi, et al.. (2020). Minodronate combined with alfacalcidol versus alfacalcidol alone for glucocorticoid-induced osteoporosis: a multicenter, randomized, comparative study. Journal of Bone and Mineral Metabolism. 38(4). 511–521. 4 indexed citations
2.
Sugimoto, Toshitsugu, Masataka Shiraki, Masao Fukunaga, et al.. (2017). 24-Month Open-Label Teriparatide Once-Weekly Efficacy Research Trial Examining Bone Mineral Density in Subjects with Primary Osteoporosis and High Fracture Risk. Advances in Therapy. 34(7). 1727–1740. 15 indexed citations
3.
Hagino, Hiroshi, Masako Ito, Junko Hashimoto, et al.. (2017). Monthly oral ibandronate 100 mg is as effective as monthly intravenous ibandronate 1 mg in patients with various pathologies in the MOVEST study. Journal of Bone and Mineral Metabolism. 36(3). 336–343. 6 indexed citations
4.
Miyamura, Nobuhiro, Hirofumi Matsuda, Yasuhiro Yamaguchi, et al.. (2016). A case of hepatitis C-associated osteosclerosis: accelerated bone turnover controlled by pulse steroid therapy. Endocrinology Diabetes and Metabolism Case Reports. 2016. 2 indexed citations
5.
Nakano, Tetsuo, et al.. (2015). Higher response with bone mineral density increase with monthly injectable ibandronate 1 mg compared with oral risedronate in the MOVER study. Journal of Bone and Mineral Metabolism. 34(6). 678–684. 8 indexed citations
6.
Nakamura, Toshitaka, Toshio Matsumoto, Toshitsugu Sugimoto, et al.. (2014). Clinical Trials Express:Fracture Risk Reduction With Denosumab in Japanese Postmenopausal Women and Men With Osteoporosis: Denosumab Fracture Intervention Randomized Placebo Controlled Trial (DIRECT). The Journal of Clinical Endocrinology & Metabolism. 99(7). 2599–2607. 125 indexed citations
7.
Nakano, Tetsuo, Masataka Shiraki, Toshitsugu Sugimoto, et al.. (2013). Once-weekly teriparatide reduces the risk of vertebral fracture in patients with various fracture risks: subgroup analysis of the Teriparatide Once-Weekly Efficacy Research (TOWER) trial. Journal of Bone and Mineral Metabolism. 32(4). 441–446. 25 indexed citations
8.
Mori, Satoshi, Satoshi Soen, Hiroshi Hagino, et al.. (2013). Justification criteria for vertebral fractures: year 2012 revision. Journal of Bone and Mineral Metabolism. 31(3). 258–261. 11 indexed citations
9.
Sugimoto, Toshitsugu, Masataka Shiraki, Tetsuo Nakano, et al.. (2012). Vertebral fracture risk after once-weekly teriparatide injections: follow-up study of Teriparatide Once-Weekly Efficacy Research (TOWER) trial. Current Medical Research and Opinion. 29(3). 195–203. 18 indexed citations
10.
Nakano, Tetsuo. (2011). [Calcium Pros and Cons--Which method is useful for diagnosis of vertebral body fracture; radiograph or MRI?--X-ray examination is not enough for diagnosis of fresh vertebral body fractures].. PubMed. 21(11). 131–5. 1 indexed citations
11.
Fukui, Naoshi, et al.. (2011). Predictors for Ambulatory Ability and the Change in ADL After Hip Fracture in Patients With Different Levels of Mobility Before Injury. Journal of Orthopaedic Trauma. 26(3). 163–171. 66 indexed citations
12.
Hagino, Hiroshi, et al.. (2011). The Risk of a Second Hip Fracture in Patients after Their First Hip Fracture. Calcified Tissue International. 90(1). 14–21. 102 indexed citations
13.
Hagino, Hiroshi, Masataka Shiraki, Masao Fukunaga, et al.. (2011). Three years of treatment with minodronate in patients with postmenopausal osteoporosis. Journal of Bone and Mineral Metabolism. 30(4). 439–446. 30 indexed citations
14.
Sakuma, Mayumi, Naoto Endo, Hiroshi Hagino, et al.. (2011). Serum 25-hydroxyvitamin D status in hip and spine-fracture patients in Japan. Journal of Orthopaedic Science. 16(4). 418–423. 20 indexed citations
15.
Ito, Manabu, Atsushi Harada, Tetsuo Nakano, et al.. (2010). Retrospective multicenter study of surgical treatments for osteoporotic vertebral fractures. Journal of Orthopaedic Science. 15(3). 289–293. 22 indexed citations
16.
Nakano, Tetsuo. (2006). [Prognosis and outcomes of hip fractures].. PubMed. 16(12). 1999–2004. 2 indexed citations
17.
Sakamoto, Keizo, Toshitaka Nakamura, Hiroshi Hagino, et al.. (2006). Report on the Japanese Orthopaedic Association’s 3-year project observing hip fractures at fixed-point hospitals. Journal of Orthopaedic Science. 11(2). 127–134. 62 indexed citations
18.
Sakamoto, Keizo, Toshitaka Nakamura, Hiroshi Hagino, et al.. (2006). Effects of unipedal standing balance exercise on the prevention of falls and hip fracture among clinically defined high-risk elderly individuals: a randomized controlled trial. Journal of Orthopaedic Science. 11(5). 467–472. 67 indexed citations
19.
Takada, Koji, et al.. (2004). Four Cases Caused Femoral Shaft Fracture after Operation of Femoral Neck Fracture. Orthopedics & Traumatology. 53(2). 358–362.
20.
Nakano, Tetsuo, et al.. (1986). Ender nailing of tibial shaft fractures.. Orthopedics & Traumatology. 34(4). 1167–1172.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Albrecht W. Popp Breakdown of academic impact, for papers by D. Algra Breakdown of academic impact, for papers by Romain Perrelet Breakdown of academic impact, for papers by Tsutomu Hashimoto Breakdown of academic impact, for papers by Anna G Nilsson Breakdown of academic impact, for papers by Christopher Shuhart Breakdown of academic impact, for papers by Richard P. Tonino Breakdown of academic impact, for papers by Giuseppina Resmini Breakdown of academic impact, for papers by T. Hashimoto Breakdown of academic impact, for papers by S. Pouwels
Rankless by CCL
2026